The psychedelic drug industry represents the best investment opportunity in life sciences of this century. A multitude of opportunities.
TSI EDITOR |
2021-07-22
The Mental Health Crisis is not only a much larger pandemic than the Covid-19 pandemic. It is also much deadlier.
TSI EDITOR |
2021-07-20
Every 10 minutes, someone in the United States commits suicide -- a suicide epidemic. Psychedelic drugs have the known potential to address and reverse this epidemic.
TSI EDITOR |
2021-07-16
As COVID-19 recedes, a much larger pandemic has been exposed -- the Mental Health Pandemic. A huge crisis; an enormous opportunity.
TSI EDITOR |
2021-07-14
"Support the troops" the White House and Congress tell Americans, over and over. When will THEY start to support the troops? Psychedelic medicine would be a great place to start.
TSI EDITOR |
2021-07-12
The U.S. Drug Enforcement Agency is a bureaucratic relic that regularly demonstrates it has no place in a world of 21st century drug reform.
TSI EDITOR |
2021-07-08
The emerging psychedelic drug sector represents the most lucrative opportunities in life sciences today. We compare and contrast six of the drug R&D leaders.
TSI EDITOR |
2021-07-06
As investors become increasingly concerned about hedging their portfolios, there are few safe alternatives. Psychedelic stocks are a sane choice for a crazy world.
TSI EDITOR |
2021-07-01
As the Mental Health Pandemic spirals out of control, we see a positive sign: the mainstream media has finally noticed it.
TSI EDITOR |
2021-06-29
Psychedelic Stock Watch explains why astute investors will put their dollars into both "experiential" and non-psychoactive psychedelic drug R&D.
TSI EDITOR |
2021-06-25
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now